You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

GSK’s follow-up to its severe asthma therapy Nucala has shown its value in a pair of phase 3 trials ... that made sales of almost £1.7 billion ($2.2 billion) last year. IL-5 is a key cytokine ...

Plus, news about Re­pare Ther­a­peu­tics, DCx Bio­ther­a­peu­tics, Blooms­bury Ge­net­ic Ther­a­pies and Zu­cara Ther­a­peu­tics: ...

Chainlink launches new rewards program distributing partner project tokens to LINK stakers, starting with 200 million SXT ...

The global quantum computing market is expected to grow exponentially in the coming decades. These two companies are foundational players in the quantum computing revolution. Quantum computing ...

Evobrutinib was the first BTK inhibitor to show proof-of-concept in a phase 2 trial, but failed two phase 3 trials in relapsing MS last year and was shelved. Fenebrutinib is in phase 3 for PPMS ...

To overcome the challenges brought by the coexistence of the switching topologies and high-order uncertain dynamics, a novel distributed optimization control method via two-layer framework is ...

Spidey wins, but his identity is revealed to the world. Uh-oh. Phase 4 mostly consisted of two things: bringing a whole bunch of new characters into the MCU and introducing the concept of the ...

Canonical actor model implementation for .NET with local + distributed actors in C# and F#.